Table 3.

Dropout causes according to the adaptation and evaluation periods

Parameter	Total	Treatment			P
		HD	HF	HDF
Dropouts in the adaptation period
deaths	2	2	0	0
kidney transplant	4	2	1	1
thrombosis or vascular access infection	1	0	1	0
withdrawal of consent	2	0	2	0
transfer to another center	1	0	1	0
no. of patients	10	4	5	1	0.127
Dropouts in the evaluation period
deaths	13	6	5	2
kidney transplant	9	3	1	5
transfer to another modality	8	2	5	1
thrombosis or vascular access infection	3	2	1	0
withdrawal of consent	2	1	0	1
transfer to another center	1	0	0	1
transfer to another study	1	1	0	0
infection	1	1	0	0
no. of patients	38	16	12	10	0.500
Total (n [%])
end of the study	98 (67.1)	50 (71.4)	19 (52.8)	29 (72.5)	0.107
death	15 (10.3)	8 (11.4)	5 (13.9)	2 (5.0)	0.403
kidney transplant	13 (8.9)	5 (7.1)	2 (5.6)	6 (15.0)	0.273
transfer to another technique	8 (5.5)	2 (2.9)	5 (13.9)	1 (2.5)	0.038
thrombosis or vascular access infection	4 (2.7)	2 (2.9)	2 (5.6)	0 (0.0)
withdrawal of consent	4 (2.7)	1 (1.4)	2 (5.6)	1 (2.5)
transfer to another center	2 (1.4)	0 (0.0)	1 (2.8)	1 (2.5)
transfer to another study	1 (0.7)	1 (1.4)	0 (0.0)	0 (0.0)
infection	1 (0.7)	1 (1.4)	0 (0.0)	0 (0.0)
no. of patients	146	70	36	40